Potential possibilities of using phage typing in elimination of multidrug resistant staphylococci

Polish Journal of Microbiology

Volumn 54, Issue 1, 2005, Pages 63-67

  Drulis Kawa, Zuzanna ^a,b   Weber Da̧browska, Beata ^c   Łusiak Szelachowska, Marzanna ^c   Doroszkiewicz, Włodzimierz ^a  

^a UNIVERSITY OF WROC AW   (Poland)

^b J Korczak Memorial Children's Hospital Wroclaw   (Poland)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Phage therapy; Staphylococci

Indexed keywords

AMINOGLYCOSIDE; AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; GENTAMICIN; MACROLIDE; OXACILLIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIOPHAGE TYPING; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CEREBROSPINAL FLUID; COAGULASE NEGATIVE STAPHYLOCOCCUS; DRUG SENSITIVITY; HUMAN; MULTIDRUG RESISTANCE; NEWBORN; NEWBORN INFECTION; RESPIRATORY SYSTEM;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIOPHAGE TYPING; COAGULASE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; MICROBIAL SENSITIVITY TESTS; POLAND; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS;

STAPHYLOCOCCI; STAPHYLOCOCCUS; STAPHYLOCOCCUS BACTERIOPHAGE;

EID: 20744460748     PISSN: 17331331     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Akatov A.K., M.L. Khatenever, G.L. Ratgauz and I.A. Parchinskaia. 1982. Coagulase-negative staphylococci isolated from patients. III. Phage typing. Zh. Mikrobiol. Epidemiol. Immunol. 2: 59-63.
2. Baquero F. 1997. Gram-positive resistance: challenge for the development of new antibiotic. J. Antimicrob. Chemother. 39 (Suppl. A): 1-6.
3. Bares I., J. Paszti and E. Czirok. 1994. Typing of coagulase-negative staphylococci isolated from immunocompromised patients. 1994. Acta Microbiol. Immunol. Hung. 41: 163-172.
4. Beck-Saque C.M., P. Azimi, S.N. Fonseca, R.S. Baltimore, D.A. Po well, L.A. Bland, M.J. Arduino, S.K. McAllister, R.S. Huberman and R.L. Sinkowitz. 1994. Bloodstream infections in neonatal intensive care unit patients: results of a multicenter study. Pediatr. Infect. Dis. J. 13: 1110-1116.
5. Biswas B., S. Adhya, P. Washart, B. Paul, A.N. Trostel, B. Powell, R. Carlton and C.R. Merril. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70: 204-210.
6. Burnie J.P., M. Naderi-Nasab and K.W. Loudon. 1997. ATI epidemiological study of blood culture isolates of coagulase-negative staphylococci demonstrating hospital-acquired infection. J. Clin. Microbiol. 35: 1746-1750.
7. Drulis-Kawa Z., E. Lewczyk, K. Korzekwa and W. Doroszkiewicz. 2002. The occurrence and antimicrobial susceptibility pattern of the microorganisms isolated from the infant blood. Post. Neonat. 1 (Suppl. II): 132-136.
8. Hall S.L. 1991. Coagulase-negative staphylococcal infections in neonates. Pediatr. Infect. Dis. J. 10: 57-67.
9. Heczko P.B., G. Pulverer, A. Kasprowicz and A. Klein. 1977. Evaluation of a new bacteriophages set for typing of Staphylococcus epidermidis strains. J. Clin. Microbiol. 5: 573-577.
10. Hiramatsu K., N. Aritaka, H. Hanaki, S. Kawasaki, Y. Hosoda, S. Hori, Y. Fukuchi and I. Kobayashi. 1997. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resisntant to vancomycin. Lancet 350: 1670-1673.
11. Holmberg O. 1978. Phage typing of coagulase-negative staphylococci. Zentralbl. Bacteriol. 241: 68-71.
12. Huebner J. and A. Kropec. 1995. Cross infections due to coagulase negative staphylococci in high risk patients. Zentralbl. Bakteriol. 283: 169-174.
13. Jarlov J.O. 1999. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility. APMIS (Suppl.) 91: 1-42.
14. Kellogg J.A., J.P. Manzella and D.A. Bankert. 2000. Frequency of low-level bacteremia in children from birth to fifteen years of age. J. Clin. Microbiol. 38: 2181-2185
15. Martin-de-Nicolas M.M., A. Vindel and J.A. Saez-Nieto. 1990. Development of a new set of phages as an epidemiological marker in Staphylococcus epidermidis causing nosocomial infections. Epidemiol. Infect. 104: 111-118.
16. National Comittee for Clinical Laboratory Standards. 2000. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Fifth Edition. M7-A5. vol. 20, no. 2. NCCLS, Wayne, PA.
17. Pfaller M.A., R.N. Jones, G.V. Doern, K. Kugler and the Sentry Participant Group. 1998. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). Antimicrob. Agents. Chemother. 42: 1762-1770.
18. Reimer L.G., M.L. Wilson and M.P. Weinstien. 1997. Update on detection of bacteremia and fungemia. J. Clin. Microbiol. 10: 444-465.
19. Richardson J.F., V.T. Rosdahl, W.J. van Leeuwen, A.M. Vickery, A. Vindel and W. Witte. 1999. Phages for methycillin-resistant Staphylococcus aureus: an international trial. Epidemiol. Infect. 122: 227-233.
20. Rosdahl V.T., B. Gahrn-Hansen, J.K. Moller and P. Kjaeldgaard. 1990. Phage-typing of coagulase-negative staphylococci. Factors influencing typability. APMIS 98: 299-304.
21. Rupp M.E. and G.L. Archer. 1994. Coagulase-negative staphylococci: pathogens associated with medical progress. Clin. Infect. Dis. 19: 231-243.
22. Sakandelidze V.M. and A.N. Meipariani. 1974. Use of combined phages in supparative-inflammatory diseases. Zh. Mikrobiol. Epidemiol. Immunobiol. 6: 135-136.
23. Sakoulas G., PA. Moise-Broder, J. Schentag, A. Forrest, R.C. Moellering, Jr and G.M. Eliopoulos. 2004. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J. Clin. Microbiol. 42: 2398-2402.
24. Sieradzki K., R.B. Roberts, D. Serur, J. Hargrave and A. Tomasz. 1999. Heterogeneously vancomycin-resistant Staphylococcus epidermidis strain causing recurrent peritonitis in a dialysis patient during vancomycin therapy. J Clin. Microbiol. 37: 39-44.
25. Skahan J.M. and J.T. Parisi. 1977. Development of a bacteriophage-typing set for Staphylococcus epidermidis. J. Clin. Microbiol. 6: 16-18.
26. Ślopek D., I. Durlakova, A. Kucharewicz-Krukowska, T. Krzywy, A. Ślopek and B. Weber. 1972. Phage typing of Shigella flexneri. Arch. Immunol. Therap. Exp. 20: 1-60.
27. Ślopek D., I. Durlakova, A. Kucharewicz-Krukowska, T. Krzywy, A. Ślopek and B. Weber. 1973. Phage typing of Shigella sonnet. Arch. Immunol. Therap. Exp. 21: 1-161.
28. Ślopek S., I. Durlakova, B. Weber-Da̧browska, A. Kucharewicz-Krukowska, M. Da̧browski and R. Bisikiewicz. 1981a. Results of Bacteriophage Treatment of Suppurative Bacterial Infections I. General Evaluation of the Results. Arch. Immunol. Ther. Exp. 31: 267-291.
29. Ślopek S., I. Durlakova, B. Weber-Da̧browska, A. Kucharewicz-Krukowska, M. Da̧browski and R. Bisikiewicz. 1981b. Results of Bacteriophage Treatment of Suppurative Bacterial Infections II. Detailed Evaluation of the Results. Arch. Immunol. Ther. Exp. 31: 293-327.
30. Ślopek S., I. Durlakova, B. Weber-Da̧browska, M. Da̧browski and A. Kucharewicz-Krukowska. 1984. Results of Bacteriophage Treatment of Suppurative Bacterial Infections III. Detailed Evaluation of the Results Obtained in Further 150 Cases. Arch. Immunol. Ther. Exp. 32: 317-335.
31. Smith T.L., M.L. Pearson, K.R. Wilcox, C. Cruz, M.V. Lancaster, B. Robinson-Dunn, F.C. Tenover, M.J. Zervos, J.D. Band, E. White and W.R. Jarvis. 1999. Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group. N. Engl. J. Med. 340: 493-501.
32. Sulakvelidze A., Z. Alavidze and J.G. Morris, Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45: 649-659.
33. Talbot H.W. and J. Parisi. 1976. Phage typing of Staphylococcus epidermidis. J. Clin. Microbiol. 3: 519-523.
34. Villari P., C. Sarnataro and L. Iacuzio. 2000. Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J. Clin. Microbiol. 38: 1740-1746
35. Verhoef J., C.P.A. van Boven and K.C. Winkler. 1972. Phage-typing of coagulase-negative staphylococci. J. Med. Microbiol. 5: 9-19.
36. Von Eiff C., R.R. Reinert, M. Kresken, J. Brauers, D. Hafner and G. Peters. 2000. Nationwide German multicentre study on prevalence of antibiotic resistance in staphylococcal bloodstream isolates and comparative in vitro activities of quinupristin-dalfopristin. J. Clin. Microbiol. 38: 2819-2823.
37. Weber-Da̧browska B., M. Mulczyk and A. Górski. 2003. Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man. Transp. Proc. 35: 1385-1386.
38. Weber-Da̧browska B., M. Mulczyk and A. Górski. 2000. Bacteriophage therapy of bacterial infections: an update of our Institute's experience. Arch. Immunol. Ther. Exp. 48: 547-551.
39. Weber-Da̧browska B., M. Mulczyk and A. Górski. 2001. Bacteriophage therapy for infections in cancer patients. Clinical Applied Immunol. Rev. 1: 131-134.
40. Weinstein M.P., S. Mirrett, L. van Pelt, M. McKinnon, B.L. Zimmer, W. Kloos and L.B. Reller. 1998. Clinical importance of identifying coagulase-negative staphylococci isolated from blood cultures: evaluation of MicroScan Rapid and Dried Overnight Gram-Positive Panels versus a conventional reference method. J. Clin. Microbiol. 36: 2089-2092
41. Zawieja M., W. Kȩdzia, B. Weber-Da̧browska and M. Da̧browski. 1986. The usefulness of the method of phagotyping of Escherichia coli strains in the epidemiological investigations in an intensive medical care unit. Anest. Intens. Therap. 18: 274-278.
42. Zhukov-Verezhnikov N.N., L.D. Peremitina, E.A. Berillo, V.P. Komissarov, V.M. Bardymov, A.G. Khvoles and L.B. Ugryumov. 1978. A study of the therapeutic effect of bacteriophages agents in a complex treatment of suppurative surgical diseases. Sov. Med. 12: 64-66.